References
- 1. S. John, M. Schlaich, M. Langenfeld, H. Weihprecht, G. Schmitz, G. Weidinger and R. E. Schmieder, Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study, Circulation 98 (1998) 211-216; DOI: org/10.1161/01.CIR.98.3.211.
- 2. C. Golias, A. Batistattou, G. Bablekos, A. Charalabopoulos, D. Peschos, P. Mitsopoulos and K. Charalabopoulos, Physiology and pathophysiology of selectins, integrins, and IgSF cell adhesion molecules focusing on inflammation. A paradigm model on infectious endocarditis, Cell. Commun. Adhes. 18 (2011) 19-32; DOI: org/10.3109/15419061.2011.606381.10.3109/15419061.2011.606381
- 3. O. Ciftci, M. Caliskan, H. Gullu, D. Erdogan, S. Topcu, O. Guler, A. Yildirir and A. H. Muderrisoglu, Acute effects of smoking light cigarettes on coronary microvascular functions, Clin. Cardiol. 32 (2009) 210-214; DOI: org/10.1002/clc.20343.10.1002/clc.20343
- 4. S. Kosaka, N. Pelisch, M. Rahman, D. Nakano, H. Hitomi, H. Kobori, N. Fukuoka, H. Kobara, H. Mori, T. Masaki, L. Cervenka, Y. Matsumura, H. Houchi and A. Nishivama, Effects of angiotensin II AT(1)-receptor blockade on high fat diet-induced vascular oxidative stress and endothelial dysfunction in Dahl salt-sensitive rats, J. Pharmacol. Sci. 121 (2013) 95-102.10.1254/jphs.12169FP
- 5. G. Y. Belgore, H. Lip and A. D. Blann, Basic fibroblast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells, Eur. J. Clin. Invest. 33 (2003) 833-839; DOI: 10.1046/j.1365-2362.2003.01223.x.10.1046/j.1365-2362.2003.01223.x
- 6. C. Muraki, N. Ohga, Y. Hida, H. Nishihara, Y. Kato, K. Tsuchiya, K. Matsuda, Y. Totsuka, M. Shindoh and K. Hida, Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells, Int. J. Cancer 130 (2012): 59-70; DOI: org/10.1002/ijc.25976.
- 7. A. M. Olsen, E. L. Fosbøl, J. Lindhardsen, C. Andersson, F. Folke, M. B. Nielsen, L. Køber, P. R. Hansen, C. Torp-Pedersen, G. H. Gislason; Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients - a nationwide study, PLoS One 8 (2013):e54309; DOI: 10.1371/journal.pone.0054309.10.1371/journal.pone.0054309
- 8. N. Bhala, J. Emberson, A. Merhi, S. Abramson, N. Arber, J. A. Baron, C. Bombardier, C. Cannon, M. E. Farkouh, G. A. FitzGerald, P. Goss, H. Halls, E. Hawk, C. Hawkey, C. Hennekens, M. Hochberg, L. E. Holland, P. M. Kearney, L. Laine, A. Lanas, P. Lance, A. Laupacis, J. Oates, C. Patrono, T. J. Schnitzer, S. Solomon, P. Tugwell, K. Wilson, J. Wittes and C. Baigent, Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials, Lancet 31 (2013) 769-779; DOI: 10.1016/ S0140-6736(13) 60900-9.
- 9. H. C. Yao, T. Liu, X. Y. Meng, Q. F. Han, M. Zhang and L. X. Wang, Effect of basic fibroblast growth factor on the myocardial expression of hypoxia-inducible factor-1a and vascular endothelial growth factor following acute myocardial infarction, Heart Lung Circ. (in press); DOI: 10.1016/j.hlc.2013.04.111.10.1016/j.hlc.2013.04.111
- 10. S. Wu, X. Wu, W. Zhu, W. J. Cai, J. Schaper and W. Schaper, Immunohistochemical study of the growth factors, aFGF, bFGF, PDGF-AB, VEGF-A and its receptor (Flk-1) during arteriogenesis, Mol. Cell. Biochem. 343 (2010) 223-229; DOI: 10.1007/s11010-010-0517-3.10.1007/s11010-010-0517-3
- 11. J. A. Paramo, J. A. Rodriguez, O. Beloqui and J. Orbe, Monocyte cyclooxygenase-2 activity: a new therapeutic target for atherosclerosis? Current Drug Targets-Cardiovasc. Haemat. Dis. 5 (2005) 303-311; DOI: org/10.2174/1568006054553381.10.2174/1568006054553381
- 12. A. Cucina, V. Borrelli, B. Randone, P. Coluccia, P. Sapienza and A. Cavallaro, Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells, J. Surg. Res. 109 (2003) 16-23; DOI: org/10.1016/S0022-4804(02)00042-2.10.1016/S0022-4804(02)00042-2
- 13. S. Flis, D. Soltysiak-Pawluczuk, A. Jedrych, Z. Jastrzebski, M. Remiszewska and J. Splawinski, Antiangiogenic effect of sulindac sulfide could be secondary to induction of apoptosis and cell cycle arrest, Anticancer Res. 26 (2006) 3033-3042.
- 14. Q. Chen, W. L. Liu, X. Guo, Y. J. Li and Z. G. Guo, Biphasic effect of aspirin on apoptosis of bovine vascular endothelial cells and its molecular mechanism, Acta Pharmacol. Sin. 28 (2007) 353-358; DOI: org/10.1111/j.1745-7254.2007.00518.x.10.1111/j.1745-7254.2007.00518.x17302997
- 15. E. Niederburger, C. Manderscheid, S. Grosch, H. Schmidt, C. Ehnert and G. Geisslinger, Effects of selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells, Biochem. Pharmacol. 68 (2004) 341-350; DOI: org/10.1016/j.bcp.2004.03.029.10.1016/j.bcp.2004.03.029
- 16. S. Boonmasawai, P. Akarasereenont, K. Techatraisak, A. Thaworn, S. Chotewuttakorn and T. Palo, Effects of selective COX-inhibitors and classical NSAIDs on endothelial cell proliferation and migration induced by human cholangiocarcinoma cell culture, J. Med. Assoc. Thai 92 (2009) 1508-1515.
- 17. P. Akarasereenont, Y. S. Bakhle, C. Thiemermann and J. R. Vane, Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide, Br. J. Pharmacol. 115 (1995) 401-408; DOI: 10.1111/j.1476-5381.1995. tb16347.x.
- 18. M. Namiecinska, A. Wiktorowska-Owczarek, A. Loboda, J. Dulak and J. Z. Nowak, Cyclic AMP generating system in human microvascular endothelium is highly responsive to adrenaline, Pharmacol. Rep. 58 (2006) 884-889.
- 19. A. Loboda, A. Jazwa, B. Wegiel, A. Jozkowicz and J. Dulak, Heme oxygenase-1-dependent and -independent regulation of angiogenic expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells, Cell. Mol. Biol. 51 (2005) 347-355.
- 20. A. Loboda, A. Jazwa, A. Jozkowicz, G. Molema and J. Dulak, Angiogenic transcriptome of human microvascular endothelial cells: effect of hypoxia, modulation by atorvastatin, Vascul. Pharmacol. 44 (2006) 206-214; DOI: org/10.1016/j.vph.2005.11.007.
- 21. F. Grasselli, G. Basini, S. Bussolati and F. Bianco, Cobalt chloride, a hypoxia-mimicking agent, modulates redox status and functional parameters of cultured swine granulose cells, Reprod. Fer. Dev. 17 (2005) 715-720.10.1071/RD05059
- 22. A. Wiktorowska-Owczarek, M. Józbwiak-Bezbenista and J. Z. Nowak, Effects of hypoxia on cyclic AMP signaling and VEGF/bFGF generation in different types of cultured cells, Pharmacol. Rep. 63 (2011) 574-575. 10.1016/S1734-1140(11)70545-X